Pediatric Anthrax Clinical Management
Authors:
- John S. BradleyJBJohn S. Bradley
- Georgina PeacockGPGeorgina Peacock
- Steven E. KrugSKSteven E. Krug
- William A. BowerWBWilliam A. Bower
- Amanda C. CohnACAmanda C. Cohn
- Dana Meaney-DelmanDMDana Meaney-Delman
- Andrew T. PaviaAPAndrew T. Pavia
- AAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCILACAAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCIL
- Sarita ChungSCSarita Chung
- Daniel B. FagbuyiDFDaniel B. Fagbuyi
- Margaret FisherMFMargaret Fisher
- Scott NeedleSNScott Needle
Open Access
- 1 May 2014
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 133 (5) , e1411-e1436
Abstract
Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as “children”) in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.Keywords
This publication has 108 references indexed in Scilit:
- Pharmacokinetics of Moxifloxacin in an Infant With Mycoplasma hominis MeningitisThe Pediatric Infectious Disease Journal, 2012
- Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal InfectionsThe Pediatric Infectious Disease Journal, 2011
- Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous MeningitisAntimicrobial Agents and Chemotherapy, 2011
- Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonatesBMC Pediatrics, 2010
- Meropenem Pharmacokinetics in the NewbornAntimicrobial Agents and Chemotherapy, 2009
- Conference Report on Public Health and Clinical Guidelines for AnthraxEmerging Infectious Diseases, 2008
- Pharmacokinetics of Penicillin G in Infants with a Gestational Age of Less than 32 WeeksAntimicrobial Agents and Chemotherapy, 2007
- Pharmacokinetics of Penicillin G in Very-Low-Birth-Weight NeonatesAntimicrobial Agents and Chemotherapy, 2007
- Prospective Determination of Plasma Imipenem Concentrations in Critically Ill ChildrenAntimicrobial Agents and Chemotherapy, 2006
- The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaNature, 2003